VIRIDIAN THERAPEUTICS INC
VRDNNASDAQ🏆 #1627 by market capEarnings Nov 4US Equity
$22.97▼ $0.09 (−0.39%)
Market closed · at close1h—
24h▼ 0.4%
7d▲ 9.1%
14d▲ 15.5%
30d▲ 21.1%
1y▲ 27.9%
🏦Market Cap
$2.54B
Small Cap
📈Revenue Growth (YoY)
+23220.3%
High Growth
📊Gross Margin
2.4%
Thin
💵FCF Margin
—
⚖️P/S Ratio
35.1x
Expensive
Otter Score
55
Weak
Earnings
Q3 · 2026Reported 2026-08-06Earnings Per Share
Actual
-1.05
Expected
-1.03
miss
−1.90%
YoY −5.00%
Revenue
Actual
$284.00K
Expected
$56.36K
beat
+403.90%
YoY +278.70%
Consensus estimates
Recent quarters
Q3 2026
-1.05
miss
Q2 2026
-0.90
beat
Q1 2026
-1.08
miss
Q4 2025
-0.34
beat